Phase 2 Leukaemia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 or older
- People who have been diagnosed with myelodysplastic syndromes, a myelodysplastic/myeloproliferative neoplasm, or acute myeloid leukaemia
- People who are receiving a less intensive form of chemotherapy (either as a first treatment or after a previous treatment has stopped working)
- People who have very low platelet counts — either 30 or below, or 50 or below before chemotherapy begins (platelets are the cells that help blood clot)
Who may not be able to join:
- People whose clinical team believes they are unlikely to survive more than 30 days
- People who are not able to give their own informed consent to participate
- People with a known allergy to tranexamic acid (the medication being studied)
- People who currently have an active blood clotting condition (such as a blood clot in a vein or artery)
- People with active ischemic heart disease (a condition where the heart is not getting enough blood flow)
- People with significant bleeding in the urine
- People with stage 5 chronic kidney disease (the most severe stage of long-term kidney failure)
- People whose doctors suspect they have a serious clotting and bleeding disorder called disseminated intravascular coagulation (DIC)
- People who are pregnant or breastfeeding
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 204-787-8552
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Patient enrollment feasibility
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.